Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Arcutis and Sato Enter Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan

Thursday, February 29, 2024

Arcutis Biotherapeutics Inc and Sato Pharmaceutical Co Ltd have announced a strategic collaboration and licensing agreement for the development production and commercialization of topical roflumilast in Japan

QIAGEN Introduces AI-Driven Biomedical Knowledge Base for Accelerating Data-Enabled Drug Discovery

Wednesday, February 28, 2024

QIAGEN has introduced QIAGEN Biomedical KBAI a novel knowledge base powered by generative AI aimed at transforming drug discovery within the pharmaceutical and biotech sectors

Myriad Genetics and National Cancer Center Hospital East in Japan Partner on Pan-Cancer MRD Monitoring Clinical Trial: SCRUM-MONSTAR-SCREEN-3

Wednesday, February 28, 2024

Myriad Genetics Inc a leading company in genetic testing and precision medicine has announced a research collaboration with Japans National Cancer Center Hospital East

Takeda and Biological E. Limited Collaborate to Expedite Dengue Vaccine Availability in Endemic Areas

Tuesday, February 27, 2024

Takeda and Biological E Limited an Indian pharmaceutical company have recently joined forces in a strategic partnership to expedite access to QDENGA Dengue Tetravalent Vaccine

Everest Medicines and Kezar Life Sciences Obtain IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

Tuesday, February 27, 2024

Today Everest Medicines and Kezar Life Sciences Inc announced that the Center for Drug Evaluation of Chinas National Medical Products Administration has approved Kezars investigational new drug

Teva and Jiangsu Nhwa Establish Strategic Collaboration to Enhance Patient Access to AUSTEDO® in China

Monday, February 26, 2024

Teva Pharmaceutical Investments Singapore Pte Ltd a subsidiary of Teva Pharmaceutical Industries Ltd has partnered with Jiangsu Nhwa Pharmaceutical Co Ltd

CSL Vifor and Travere Therapeutics Announce That Sparsentan Has Obtained a Positive CHMP Opinion for the Treatment of IgA Nephropathy

Saturday, February 24, 2024

CSL Vifor and Travere Therapeutics Inc jointly announced today that the European Medicines Agencys Committee for Medicinal Products for Human Use has recommended the approval of sparsentan

Rhythm Pharmaceuticals Reveals Clinical Development Strategy for Setmelanotide in Addressing Hypothalamic Obesity in Japan

Friday, February 23, 2024

Rhythm Pharmaceuticals Inc a global commercialstage biopharmaceutical company specializing in rare neuroendocrine diseases has announced plans to expand its ongoing global Phase clinical trial

Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®

Friday, February 23, 2024

Ligand Pharmaceuticals Incorporated has announced that Eisai Co Ltd its partner has received approval for the injection formulation of their antiepileptic drug Fycompa

WuXi Advanced Therapies Receives FDA Approval for Manufacturing Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

Thursday, February 22, 2024

WuXi Advanced Therapies a subsidiary of WuXi AppTec has received approval from the US Food and Drug Administration to initiate analytical testing and manufacturing of AMTAGVI for Iovance